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did the total group of 71 diabetic patients have a lower
red blood cell deformability when compared to controls.
Extaerythrocytic factors, such as leukocytes, plasma fib-
rinogen, and platelet microaggregates may influence fil-
tration results. I suppose the filtration technique of Brown
et al was corrected for this. These results may suggest that
the filtration pore size of 3 micrometers used by Brown et
al was more sensitive than the 5 micrometer pores filtra-
tion technique and ektacytometry that was used by us and
that the lack of difference in our patient groups reflects
this lack of sensitivity. On the other hand, the question
arises whether such subtle differences in red blood cell
deformability, if present, contribute to nephropathy in
diabetic patients.
NIELS H. SCHUT
Haarlem, The Netherlands
Correspondence to Niels H. Schut, Department of Internal Medicine,
Kennemer Gasthuis, Haarlem,the Netherlands.
E-mail: schutn@kg.nl
REFERENCES
1. BROWN CD, GHALI HS, ZHAO Z, et al: Association of reduced
red blood cell deformability and diabetic nephropathy. Kidney Int
67:295–300, 2005
2. SCHUT NH, VAN ARKEL EC, HARDEMAN MR, et al: No decreased ery-
throcyte deformability in type 1 (insulin-dependent) diabetes, either
by filtration or by ektacytometry. Acta Diabetol 30:89–92, 1993
Reply from the Authors
We wish to thank Dr. Schut for their interest in our
study [1], and would like to reply to the issues raised in
their letter to the Editor.
We think that the results of our study do not agree with
those reported in their article published in 1993 [2] for
reasons stated in their letter. For example, we removed
leukocytes and platelets before measuring RBC deforma-
bility (RBC-df), and we opted to use the more sensitive
3 micron pore filter instead of a 5 micron pore filter.
To address the question of whether changes in RBC-
df contributes to diabetic nephropathy, we do not know
whether impaired RBC-df is a cause or consequence of
diabetic nephropathy.
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Postprocedural drop in
hematocrit versus
contrast-induced nephropathy:
Eggs or chickens?
To the Editor: In a recent issue of Kidney International,
Nikolsky et al suggested that low hematocrit (Hct) pre-
dicts contrast-induced nephropathy (CIN) after percuta-
neous coronary interventions (PCI) [1]. One impressive
finding in this study was that the postprocedural drop
in Hct (Hct = baseline Hct − postprocedural nadir
Hct) was highly correlated with CIN. However, we won-
der whether Hct resulted in CIN or, on the contrary,
it was attributed to CIN. Assuming that there was no
significant postprocedural change of body weight (BW)
or fluid status in the patients receiving PCI, Hct might
exactly reflect acute blood loss. The most possible route
of the blood loss was extravascular loss (e.g., bleeding,
hematoma, catheter aspiration, etc.) rather than intravas-
cular hemolysis. Hence, the amount of the procedure-
related extravascular blood loss (EVBL) could be esti-
mated by the following equations [2]:
Blood volume = plasma volume/(1 − Hct) = BW
× (60% × 40% × 20%)/(1 − Hct);
EVBL (L) = BW (kg) × (60% × 40% × 20%)
× Hct/[(1 − baseline Hct)
(1 − baseline Hct + Hct)]
In a male patient with a BW of 70 kg, baseline Hct
40%, Hct 6%, his estimated EVBL would be 510 mL.
Actually, the average amount of EVBL after PCI rarely
exceeded 100∼200 mL. This could not explain the large
gap from the estimated data. On the contrary, Hct might
also be attributed to fluid retention-induced hemodi-
lution secondary to CIN. The proportional increase of
serum creatinine must overcome the dilute effect of
acute fluid retention before meeting the definition of
CIN (i.e., an increase of ≥25% or ≥0.5 mg/dL in pre-
PCI serum creatinine at 48 hours post-PCI) [3, 4]. Precise
